Healthcare is one of the largest contributors to the UK’s carbon footprint. The NHS has a target for net zero emissions by 2040, with improved waste recycling. Literature demonstrates need for greater engagement with recycling: one audit found over 40% of all hospital waste is recyclable. Despite this, recycling is not commonplace in healthcare settings.
Methods
We started our project with a GEMBA walk, evaluating the patient journey through the department and identified areas we could make greener. We then surveyed staff, asking what was the most important and sustainable project, identifying recycling. We began our quality improvement project by gathering information about commonly recyclable items, before educating staff during a department-wide teaching session. Following this, we introduced educational posters to reinforce knowledge and prompt staff to recycle. After each intervention, we weighed the recycling and assessed understanding with a quiz.
Results
There was an increase in knowledge of recycling amongst staff; 84% correctly identified recyclable items compared to 47% before the teaching. So far, we have observed no significant increase in weight of the recycling bins with weekly averages of 2kg to 2.1kg.
Discussion
There was an increase in recycling knowledge despite the recycling weight being unchanged. At the beginning of our project we observed non-recyclable items being disposed of in the recycling. Therefore, a static weight may reflect positive change in practice. Findings demonstrated barriers to recycling included lack of bins. Our next intervention will be increasing the recycling bin availability, to make changes more accessible and sustainable. We observed wide variations in recycling information printed on medical packaging, and believe this is something that should be systemically changed. Recommendations from this project are to increase access to recycling bins, increase clarity of recycling information on products and make recycling data more available to clinics to monitor sustainability over time.
{"title":"UG4 Greener sexual health: increasing awareness and engagement with recycling in an integrated sexual health service","authors":"Lowenna Riley, Nadia Vryoni-Dickson, Mohamed El-Gazzar, Joanna Rees, Derval Harte","doi":"10.1136/sextrans-bashh-2023.40","DOIUrl":"https://doi.org/10.1136/sextrans-bashh-2023.40","url":null,"abstract":"<h3>Introduction</h3> Healthcare is one of the largest contributors to the UK’s carbon footprint. The NHS has a target for net zero emissions by 2040, with improved waste recycling. Literature demonstrates need for greater engagement with recycling: one audit found over 40% of all hospital waste is recyclable. Despite this, recycling is not commonplace in healthcare settings. <h3>Methods</h3> We started our project with a GEMBA walk, evaluating the patient journey through the department and identified areas we could make greener. We then surveyed staff, asking what was the most important and sustainable project, identifying recycling. We began our quality improvement project by gathering information about commonly recyclable items, before educating staff during a department-wide teaching session. Following this, we introduced educational posters to reinforce knowledge and prompt staff to recycle. After each intervention, we weighed the recycling and assessed understanding with a quiz. <h3>Results</h3> There was an increase in knowledge of recycling amongst staff; 84% correctly identified recyclable items compared to 47% before the teaching. So far, we have observed no significant increase in weight of the recycling bins with weekly averages of 2kg to 2.1kg. <h3>Discussion</h3> There was an increase in recycling knowledge despite the recycling weight being unchanged. At the beginning of our project we observed non-recyclable items being disposed of in the recycling. Therefore, a static weight may reflect positive change in practice. Findings demonstrated barriers to recycling included lack of bins. Our next intervention will be increasing the recycling bin availability, to make changes more accessible and sustainable. We observed wide variations in recycling information printed on medical packaging, and believe this is something that should be systemically changed. Recommendations from this project are to increase access to recycling bins, increase clarity of recycling information on products and make recycling data more available to clinics to monitor sustainability over time.","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136169658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1136/sextrans-bashh-2023.38
Aniruddh Shenoy, Pavan Kaur Marwaha, Dominic Adam Worku
Introduction
Encephalitis is a life-threatening neurological condition. CD8 Encephalitis (CD8E) is a newly recognised condition in the setting of Human Immunodeficiency Virus (HIV) infection which can present acutely with classical radiological findings and brain parenchymal infiltration of CD8+ T-cells. This review attempted to clarify symptomatology and determinants of this condition.
Methods
A literature review was conducted, utilising PubMed and Google Scholar databases, reviewing papers published between 2006–2022. Eighteen papers, totalling 57 patients, were identified and analysed. Statistical analysis was undertaken using Chi-squared and Wilcoxon rank-sum tests, with p<0.05 deemed significant.
Results
Among the cohort, a female (61%) and Black African (70%) preponderance was identified. Headache was commoner in females (p=0.006) and in those who died (p=0.02). There was no statistically significant association between baseline CD4 count (p=0.079) and viral load (p=0.72) with mortality. Overall, 77% of patients had classical radiological findings of gadolinium-enhancing punctate and perivascular white matter lesions, with many requiring a brain biopsy to confirm the diagnosis. CSF analysis typically showed lymphocytic pleocytosis, demonstrating CD8+ predominance in 90% of where the lymphocyte subset was tested. Corticosteroids were commonly prescribed (64%) and demonstrated mortality benefit, with an overall survival in this group of 71% (p=0.0008). In those who died, the median survival was 5.5 months.
Discussion
Amongst symptoms, headache appeared more common in females and was significantly associated with death. CD8E is likely under-diagnosed, possibly due to overlapping features with other illnesses and lack of physician experience. Corticosteroids demonstrated a mortality benefit, but more studies should determine their optimal dosing, duration, and use of steroid-sparing agents. Further research should better identify risk factors and non-invasive biomarkers to predict poor prognosis and disease recurrence.
{"title":"UG2 CD8 encephalitis in HIV: a review of this emerging entity","authors":"Aniruddh Shenoy, Pavan Kaur Marwaha, Dominic Adam Worku","doi":"10.1136/sextrans-bashh-2023.38","DOIUrl":"https://doi.org/10.1136/sextrans-bashh-2023.38","url":null,"abstract":"<h3>Introduction</h3> Encephalitis is a life-threatening neurological condition. CD8 Encephalitis (CD8E) is a newly recognised condition in the setting of Human Immunodeficiency Virus (HIV) infection which can present acutely with classical radiological findings and brain parenchymal infiltration of CD8+ T-cells. This review attempted to clarify symptomatology and determinants of this condition. <h3>Methods</h3> A literature review was conducted, utilising PubMed and Google Scholar databases, reviewing papers published between 2006–2022. Eighteen papers, totalling 57 patients, were identified and analysed. Statistical analysis was undertaken using Chi-squared and Wilcoxon rank-sum tests, with p&lt;0.05 deemed significant. <h3>Results</h3> Among the cohort, a female (61%) and Black African (70%) preponderance was identified. Headache was commoner in females (p=0.006) and in those who died (p=0.02). There was no statistically significant association between baseline CD4 count (p=0.079) and viral load (p=0.72) with mortality. Overall, 77% of patients had classical radiological findings of gadolinium-enhancing punctate and perivascular white matter lesions, with many requiring a brain biopsy to confirm the diagnosis. CSF analysis typically showed lymphocytic pleocytosis, demonstrating CD8+ predominance in 90% of where the lymphocyte subset was tested. Corticosteroids were commonly prescribed (64%) and demonstrated mortality benefit, with an overall survival in this group of 71% (p=0.0008). In those who died, the median survival was 5.5 months. <h3>Discussion</h3> Amongst symptoms, headache appeared more common in females and was significantly associated with death. CD8E is likely under-diagnosed, possibly due to overlapping features with other illnesses and lack of physician experience. Corticosteroids demonstrated a mortality benefit, but more studies should determine their optimal dosing, duration, and use of steroid-sparing agents. Further research should better identify risk factors and non-invasive biomarkers to predict poor prognosis and disease recurrence.","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136170506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1136/sextrans-bashh-2023.11
Hannah Charles, Mateo Prochazka, Judith Murray, Suneeta Soni, Lewis Haddow, Katie Beets, Victoria Pilkington, Nicola Low, Sophie Candfield, Rachael Jones, Tanya Bleiker, Claire Dewsnap, Matt Phillips, David Phillips
Introduction
To understand the clinical presentation, severity and epidemiology of individuals with Mpox attending sexual health services (SHSs) in England, we developed a tool for Surveillance of Mpox Cases Attending Sexual Health Services (SOMASS).
Methods
Experts from the UK Health Security Agency (UKHSA), British Association of Sexual Health and HIV and the British Association of Dermatologists formed a multi-disciplinary working group in May 2022 and co-developed a web-based data collection tool. The UKHSA hosted the tool, which was accessible from July 2022. SHS clinicians abstracted information from clinical records into SOMASS following consultations with patients suspected to have Mpox.
Results
As of 17th November 2022, 276 SOMASS responses were submitted from 31 SHSs in England, representing 8% of all confirmed Mpox cases in England as of 14th November 2022. Of these, 274 were subsequently laboratory-confirmed Mpox positive; in two cases the laboratory result was unknown but assumed to be positive, and therefore these individuals were retained for analysis. Where recorded, most (245/261; 94%) people identified as gay, bisexual or men who have sex with men (GBMSM). For 46% (127/276), dermatological lesions were the initial symptom. Lesions were mostly asymmetrical and polymorphic, predominately affecting genital area and perianal areas. Among GBMSM, we found an association between receptive anal intercourse and proctitis (27/115; 24% vs. 7/130; 5%; p<0.0001), and perianal lesions as the primary lesion site (46/115; 40% vs. 25/130; 19%; p=0.0003).
Discussion
SOMASS demonstrates multi-disciplinary, responsive, and agile working between front-line sexual health practitioners, clinical professional bodies and the national health protection agency. The data collection tool improved surveillance, strengthened the knowledge base and supported clinical care during the Mpox outbreak. This tool will be ready to capture resurgences of Mpox in England and the development process could be adapted to future outbreaks.
为了了解英格兰接受性健康服务(SHSs)的m痘患者的临床表现、严重程度和流行病学，我们开发了一个接受性健康服务的m痘病例监测工具(SOMASS)。方法来自英国卫生安全局(UKHSA)、英国性健康与艾滋病毒协会和英国皮肤科医生协会的专家于2022年5月组成了一个多学科工作组，共同开发了一个基于网络的数据收集工具。该工具由UKHSA托管，可从2022年7月起访问。SHS临床医生在与疑似m痘患者会诊后将临床记录中的信息提取到SOMASS中。截至2022年11月17日，英国31家SHSs提交了276例SOMASS应答，占截至2022年11月14日英国所有确诊Mpox病例的8%。其中274人后来经实验室确认为Mpox阳性;在两个病例中，实验室结果是未知的，但假定是阳性的，因此这些个体被保留下来进行分析。有记录的最多(245/261;94%)被认定为同性恋、双性恋或男男性行为者(GBMSM)。46%(127/276)患者的初始症状为皮肤病变。病变多为不对称和多形，主要影响生殖器区和肛周区。在GBMSM中，我们发现接受性肛交与直肠炎之间存在关联(27/115;24% vs. 7/130;5%;P<0.0001)，肛周病变为原发部位(46/115;40% vs. 25/130;19%;p = 0.0003)。SOMASS展示了一线性健康从业者、临床专业机构和国家健康保护机构之间多学科、反应迅速和敏捷的工作。数据收集工具改善了监测，加强了知识库，并在麻疹暴发期间支持了临床护理。该工具将准备好捕捉英格兰Mpox的复发，并且开发过程可以适应未来的暴发。
{"title":"O11 Surveillance of Mpox cases attending sexual health services in England (SOMASS): design, implementation and initial findings from the SOMASS data collection tool, 2022","authors":"Hannah Charles, Mateo Prochazka, Judith Murray, Suneeta Soni, Lewis Haddow, Katie Beets, Victoria Pilkington, Nicola Low, Sophie Candfield, Rachael Jones, Tanya Bleiker, Claire Dewsnap, Matt Phillips, David Phillips","doi":"10.1136/sextrans-bashh-2023.11","DOIUrl":"https://doi.org/10.1136/sextrans-bashh-2023.11","url":null,"abstract":"<h3>Introduction</h3> To understand the clinical presentation, severity and epidemiology of individuals with Mpox attending sexual health services (SHSs) in England, we developed a tool for Surveillance of Mpox Cases Attending Sexual Health Services (SOMASS). <h3>Methods</h3> Experts from the UK Health Security Agency (UKHSA), British Association of Sexual Health and HIV and the British Association of Dermatologists formed a multi-disciplinary working group in May 2022 and co-developed a web-based data collection tool. The UKHSA hosted the tool, which was accessible from July 2022. SHS clinicians abstracted information from clinical records into SOMASS following consultations with patients suspected to have Mpox. <h3>Results</h3> As of 17th November 2022, 276 SOMASS responses were submitted from 31 SHSs in England, representing 8% of all confirmed Mpox cases in England as of 14th November 2022. Of these, 274 were subsequently laboratory-confirmed Mpox positive; in two cases the laboratory result was unknown but assumed to be positive, and therefore these individuals were retained for analysis. Where recorded, most (245/261; 94%) people identified as gay, bisexual or men who have sex with men (GBMSM). For 46% (127/276), dermatological lesions were the initial symptom. Lesions were mostly asymmetrical and polymorphic, predominately affecting genital area and perianal areas. Among GBMSM, we found an association between receptive anal intercourse and proctitis (27/115; 24% vs. 7/130; 5%; p<0.0001), and perianal lesions as the primary lesion site (46/115; 40% vs. 25/130; 19%; p=0.0003). <h3>Discussion</h3> SOMASS demonstrates multi-disciplinary, responsive, and agile working between front-line sexual health practitioners, clinical professional bodies and the national health protection agency. The data collection tool improved surveillance, strengthened the knowledge base and supported clinical care during the Mpox outbreak. This tool will be ready to capture resurgences of Mpox in England and the development process could be adapted to future outbreaks.","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136170643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1136/sextrans-bashh-2023.2
Rona MacDonald
We describe an outbreak of 18 cases of acute symptomatic Hepatitis B (HBV) between Dec 2020- September 2022 in a low prevalence region in Scotland. All initially presented as heterosexual, 15 were male, majority were married, aged 40–70 and from a similar area. We discuss the vital input sexual health (SH) had in identifying the outbreak and liaising with partner agencies. We also review the outreach and difficulties supporting people who may not feel able to disclose risk factors (RF) especially to non SH staff 2 cases of HBV/syphilis coinfection were diagnosed in the hospital in December 2020 with no identified source of infection. When the men attended SH both disclosed male sexual contacts. Concern of a cluster was raised by SH. 9/12 passed and SH were advised of 5 further cases. SH linked with Public Health and an Incident Management Team was created which identified weakness in pathways between services to realise an outbreak. Extensive collaborative work was done to improve communication between departments and training on sexual history taking. All cases were then referred to SH, of those that attended, 5 men newly disclosed male sexual contacts, 2 were wives of cases, 7 still had no identifiable infection source Genotyping was possible for 12, 10 were type A2. This is the most common strain and associated with MSM Several collaborative outreach events were arranged, >80 contacts were made but no new cases were seen and none disclosed RF. Communications were made to general public but due to the concern of inadvertently “outing” people or creating stigma in small communities it was decided to not focus them at MSM. This outbreak highlights SH’s vital importance in supporting patients disclose and reduce infection spread. It also shows the difficulties in targeting support for people who may be unaware/unable to disclose RF.
{"title":"O02 Outbreak of acute symptomatic hepatitis B in low prevalence region in Scotland","authors":"Rona MacDonald","doi":"10.1136/sextrans-bashh-2023.2","DOIUrl":"https://doi.org/10.1136/sextrans-bashh-2023.2","url":null,"abstract":"<h3></h3> We describe an outbreak of 18 cases of acute symptomatic Hepatitis B (HBV) between Dec 2020- September 2022 in a low prevalence region in Scotland. All initially presented as heterosexual, 15 were male, majority were married, aged 40–70 and from a similar area. We discuss the vital input sexual health (SH) had in identifying the outbreak and liaising with partner agencies. We also review the outreach and difficulties supporting people who may not feel able to disclose risk factors (RF) especially to non SH staff 2 cases of HBV/syphilis coinfection were diagnosed in the hospital in December 2020 with no identified source of infection. When the men attended SH both disclosed male sexual contacts. Concern of a cluster was raised by SH. 9/12 passed and SH were advised of 5 further cases. SH linked with Public Health and an Incident Management Team was created which identified weakness in pathways between services to realise an outbreak. Extensive collaborative work was done to improve communication between departments and training on sexual history taking. All cases were then referred to SH, of those that attended, 5 men newly disclosed male sexual contacts, 2 were wives of cases, 7 still had no identifiable infection source Genotyping was possible for 12, 10 were type A2. This is the most common strain and associated with MSM Several collaborative outreach events were arranged, >80 contacts were made but no new cases were seen and none disclosed RF. Communications were made to general public but due to the concern of inadvertently “outing” people or creating stigma in small communities it was decided to not focus them at MSM. This outbreak highlights SH’s vital importance in supporting patients disclose and reduce infection spread. It also shows the difficulties in targeting support for people who may be unaware/unable to disclose RF.","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"159 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136170325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.445
F. Artime Rodríguez-Hermida, M. Perpinyà Gombau, C. Díez Vallejo, M. Olmo Martínez, MD Malla Canet, A. Dordá Benito, E. Nogué Pujadas, À. Castelló Nòria, R. Sacrest Güell
{"title":"5PSQ-061 New-onset multiple sclerosis associated with adalimumab treatment: about two case reports","authors":"F. Artime Rodríguez-Hermida, M. Perpinyà Gombau, C. Díez Vallejo, M. Olmo Martínez, MD Malla Canet, A. Dordá Benito, E. Nogué Pujadas, À. Castelló Nòria, R. Sacrest Güell","doi":"10.1136/ejhpharm-2023-eahp.445","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.445","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74885904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.434
S. Herrera Carranza, P. Sanmartín Fenollera, S. Adeva Antona, M. Prada Bou, C. S. Sanz Sánchez, I. Salvador Llana, M. Pérez Encinas
{"title":"4CPS-260 Persistence, safety and associated lymphopenia of dimethyl fumarate in relapsing remitting multiple sclerosis, real world data","authors":"S. Herrera Carranza, P. Sanmartín Fenollera, S. Adeva Antona, M. Prada Bou, C. S. Sanz Sánchez, I. Salvador Llana, M. Pérez Encinas","doi":"10.1136/ejhpharm-2023-eahp.434","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.434","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75334108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.411
C. Fraile Rodriguez, S. González Martínez, N. de Amuriza Chicharro, E. Bartolome García, A. Delgado Latorre, MA García Del Barrio
{"title":"4CPS-165 Adaptation of marketed parenteral nutrition to the needs of a hospital","authors":"C. Fraile Rodriguez, S. González Martínez, N. de Amuriza Chicharro, E. Bartolome García, A. Delgado Latorre, MA García Del Barrio","doi":"10.1136/ejhpharm-2023-eahp.411","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.411","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78200262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.397
M. Pedemonte, J. Ruíz, A. Juanes, C. Socias Cañellas, C. Martinez, L. Lozano, M. Rosado, M. Mangués
{"title":"4CPS-102 Drug related problems secondary to heparin treatment in patients discharged from the emergency department","authors":"M. Pedemonte, J. Ruíz, A. Juanes, C. Socias Cañellas, C. Martinez, L. Lozano, M. Rosado, M. Mangués","doi":"10.1136/ejhpharm-2023-eahp.397","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.397","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77448991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.463
R. O'Hare, R. Powell, S. Haughey, N. O’Boyle, F. Hughes
{"title":"6ER-002 What’s another peer? Exploring the use of near peer teaching of medication history taking in pharmacy undergraduates in the UK","authors":"R. O'Hare, R. Powell, S. Haughey, N. O’Boyle, F. Hughes","doi":"10.1136/ejhpharm-2023-eahp.463","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.463","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77812978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.429
M. Iglesias Rodrigo, C. Sebastián Carrasco, C. Sangrador Pelluz, N. Meca Casasnovas, F. Salazar González, B. Tenas Rius, J. Nicolás Picó
{"title":"4CPS-245 Prevention of refeeding syndrome in patients on parenteral nutrition: a review of appropriateness","authors":"M. Iglesias Rodrigo, C. Sebastián Carrasco, C. Sangrador Pelluz, N. Meca Casasnovas, F. Salazar González, B. Tenas Rius, J. Nicolás Picó","doi":"10.1136/ejhpharm-2023-eahp.429","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.429","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"59 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80261511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：